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Abstract  
 
Orthobiologics is a rapidly advancing field utilising cell-based therapies and biomaterials to 
enable the body to repair and regenerate musculoskeletal tissues. This paper reports on a cost-
effective flame spheroidisation process for production of novel porous glass microspheres from 
calcium phosphate based glasses to encapsulate and deliver stem cells. Careful selection of the 
glass and pore forming agent, along with a manufacturing method with the required processing 
window enabled the production of highly porous glass microspheres via a single-stage 
manufacturing process. The morphological and physical characterisation revealed porous 
microspheres with tailored surface and interconnected porosity (up to 76±5%) with average 
pore size of 55±8 µm and surface areas ranging from 0.34 to 0.9 m2g-1. Furthermore, simple 
alteration of the processing parameters produced microspheres with alternate unique 
morphologies, such as with solid cores and surface porosity only. The tuneable porosity 
enabled control over their surface area, degradation profiles and hence ion release rates. 
Furthermore, biocompatibility of the microspheres was assessed using human mesenchymal 
stem cells (hMSCs) via direct cell culture experiments and analysis confirmed that they had 
migrated to within the centre of the microspheres.  The novel microspheres developed have 
huge potential for tissue engineering and regenerative medicine applications.  
Keywords: Calcium phosphate glass, porous microspheres, stem cells. 
 
 
1. Introduction 
Orthobiologics is a rapidly advancing field which utilises cell-based therapies and biomaterials 
to promote healing. The development of orthobiologic solutions for repairing musculoskeletal 
disorders has provided clinicians alternatives to mechanical stabilisation, which has been the 
focus of orthopaedic procedures for many years. Orthobiologics have been utilised in a variety 
of different areas of medicine and their applications continue to expand [1] which is enabling 
orthobiologics to emerge as the frontline for disease treatment and has the potential to 
revolutionise medicine [2]. 
The advantages of using synthetic biomaterials over autograft and allograft bone materials are 
associated with their scale-up manufacturing and long term preservation in order to supply on-
demand [3]. It was discovered that bioactive glasses could be used to stimulate osteogenesis, 
thereby leading to the concept of tissue regeneration. It has also since been discovered that the 
dissolution ion products from these glasses could also provide signals to the cells [4].  
 
The three main types of bioactive glasses investigated for biomedical applications include 
silicates, borates and phosphate based glasses. Silicate based bioactive glasses are based on 
SiO2 (as the glass network former) and include other modifying oxides such as Na2O, CaO and 
P2O5 (and were initially developed by the late Professor Larry Hench and commercialised as 
45S5 BioglassTM [5]). They have to a great extent been applied for use in hard tissue repair [5-
7] and more recently have been added to toothpaste (Sensodyne®, Novamin™, BioMin). 
Borate based glasses (where, B2O3 is the glass network former) degrade faster than silicate-
based glasses and have also been investigated for biomedical applications [8]. Huang et al. [8] 
investigated the formulation B2O3 46.1- CaO 26.9 - Na2O 24.4 - P2O5 2.6 (in mol%) and found 
that they could convert this glass into apatite following immersion within a dilute (0.02 M) 
K2HPO4 solution. Phosphate based glasses are based on P2O5 (as the glass network former) and 
have been widely explored using Na2O and CaO including many other modifying oxides such 
as CuO [9], Ag2O [10], TiO2 [11], SrO [12], MgO [13] to  provide enhanced properties or 
biological responses [14-18].  The main advantage of phosphate glasses over the silicate 
bioglasses and bioceramic materials, include their fully degradable and controllable resorption 
profiles (which can range from days/weeks/to many months), by simply tailoring the glass 
formulations [19, 20].  
 
Microspheres (i.e. spherical particles) exhibit greater advantages over irregular-shaped 
particles such as improved flow properties, which would be particularly beneficial for 
biomedical applications (for example, by enabling improved delivery via minimally invasive 
surgical injection procedures [21]). Microparticles with hollow and/or porous morphologies 
have become extremely important in many scientific fields due to their advantageous functional 
properties. For example, hollow microspheres have been exploited as additives for adhesives 
and as fillers in construction composites due to their durability and light weight [22], whereas 
porous microparticles have been widely investigated for applications varying from stem cell 
research [23, 24], drug delivery [25], tissue engineering [26], separation sciences [27], 
supercapacitors [28]  and energy storage [29]. More recently, hollow glass microspheres with 
porous walls (with porosity on the angstrom level) have been developed and are being 
investigated to store liquids and gases within their hollow interior with the aim to release them 
on demand [30]. However, the development of highly porous glass microspheres via a simple 
manufacturing process, with controlled surface porosity levels and with interconnected 
porosity (throughout the entire microsphere), could have the potential to totally revolutionise 
the microsphere industry by enabling many other applications for these materials.   
Manufacturing processes for porous materials depend heavily on the type of material used. For 
example, techniques utilised for making porous glass and/or ceramic scaffolds commonly use 
methods such as incorporation of a removable space holder [31], polymer foam replication 
[32], sol-gel [33], gel cast foaming [34] and solid freeform methods (i.e. 3D printing) [35]. 
These manufacturing processes involve multiple processing steps which can be laborious, time 
consuming and energy intensive. The dissolution and thermal decomposition of space holders 
and sacrificial polymer templates can also result in residual contaminants which not only 
affects further processing but also the mechanical and physical properties of the resultant 
porous material. In the case of solid freeform fabrication techniques (3D printing), maintaining 
the viscosity of the ink (glass particles along with the polymer binder) is critical and can be 
time consuming requiring several steps of printing, drying and sintering [35].  
Processes utilised for manufacturing polymer based porous microspheres have mostly been via 
emulsion-solvent evaporation, spray drying and phase separation techniques [25, 36, 37]. 
Whilst, ceramic microspheres have commonly been fabricated via gelation, emulsification and 
precipitation processes [38, 39] and solid (non-porous) and hollow glass microspheres have 
been fabricated via sol-gel [40] and flame spheroidisation [41] processes. However, when 
considering the manufacture of porous glass microspheres with fully controlled surface and 
fully interconnected porosity, the main challenges have included high production costs 
alongside lengthy and/or complex manufacturing processes, scale-up limitations and control 
over porosity size, interconnected porosity and morphology.  
In this paper, the authors report a new and cost-effective process for manufacturing highly 
porous calcium phosphate (CaP) glass microspheres with tailorable surface and fully 
interconnected porosity (up to 76%) within each microsphere produced, via a single-stage 
flame spheroidisation process. Preliminary biological analyses were performed via direct cell 
culture studies using human mesenchymal stem cells including the suitability of these 
microspheres to support cell adhesion and growth. 
 
2. Materials and methods 
2.1 Manufacture of solid and porous calcium phosphate glass microspheres 
Calcium phosphate glass in the system 40P2O5·16CaO·24MgO·20Na2O (mol% denoted as 
P40) was prepared using NaH2PO4, CaHPO4, MgHPO4 and P2O5 (Sigma-Aldrich, UK) as 
starting materials. These precursors were placed into a 100 ml volume Pt/5%Au crucible and 
dried at 350oC for 30 minutes in a furnace. The sample was then melted at 1150oC for 90 
minutes. The molten glass was then quenched onto a steel plate and allowed to cool to room 
temperature.  
Once cooled, the glass was ground into microparticles using a Retsch PM100 milling machine 
and sieved into varying size ranges spanning 63-300 μm. The solid non-porous microspheres 
were produced using the flame spheroidisation method which utilised an oxy/acetylene flame 
spray gun (MK 74, Metallisation Ltd, UK). Porous glass microspheres were produced by 
introducing porogens to the glass feed, which were then fed simultaneously into the thermal 
spray gun. Post manufacture, the microspheres were collected from cooling trays and were then 
subjected to an acid wash step by gently stirring them in acetic acid (5M) for 2 min followed 
by washing using deionised water (for 5 min) and then dried in an oven at 50oC for 24 h. 
 
2.2 Characterisation methods 
2.2.1 Scanning electron microscopy (SEM) and energy dispersive X-ray (EDX) analysis 
The surface and cross-sectional morphology was qualitatively examined using scanning 
electron microscopy (SEM - Philips XL30, FEI, USA) operated at 20kV. Cross sections were 
achieved by embedding the microspheres in a cold set epoxy resin and polished with SiC paper 
followed by a diamond cloth. Quantitative compositional analysis of the CaP microspheres was 
carried out using an energy dispersive X-ray (EDX, INCA Oxford Instruments) detector at an 
accelerating voltage of 20 kV and a working distance of 10 mm. All samples were carbon 
coated using an evaporation coater (Edwards coating System E306A) in order to avoid image 
distortion due to charging. 
2.2.2 Mercury porosimetry and BET surface area analysis 
The porosity of the microspheres was investigated using mercury intrusion porosimetry 
(Micromeritics Autopore IV 9500).  A 5cc powder penetrometer (Micrometrics) with 1cc 
intrusion volume was used for all samples. An empty penetrometer test was also conducted as 
a blank before running the samples.  
The surface area was determined via gas adsorption using the BET technique (Micrometrics 
Gemini 2360) where approximately 0.5 g of the microspheres were initially degassed under 
nitrogen at 110oC for at least 2 h before performing multipoint BET analysis. 
2.2.3 Degradation and ion release studies 
Degradation analyses of the microspheres was evaluated by means of mass loss measurements 
in ultra-purified water (Milli-Q) (1% w/v) at 37oC over 28 days (the medium was refreshed 
every 2 days). The degraded microspheres were removed from the medium at various time 
points (1, 3, 7, 14, 21, and 28 days) and placed onto tissue paper to blot dry then weighed 
immediately.  
𝑀𝑎𝑠𝑠 𝐿𝑜𝑠𝑠 (%) =  
𝑀0−𝑀𝑡
𝑀0
      (1) 
Where Mo is the initial mass and Mt is the mass at test time point t. 
Ion release profiles of the microspheres was conducted in Dulbecco's Modified Eagle Medium 
(DMEM, Sigma-Aldrich, UK) cell culture media (1% w/v) over 14 days (the media was again 
refreshed every 2 days) using inductively coupled plasma mass spectrometry (ICP-MS, 
Thermo-Fisher iCAP-Q model). 
2.2.4 Cell culture study 
2.2.4.1 Preparation of CaP microspheres extract  
Porous CaP microspheres were sterilised through two 15-min wash steps using 70% EtOH. 
After complete evaporation of 70% EtOH at room temperature in sterile conditions, porous 
microspheres were soaked in standard cell culture (SC) medium (low glucose DMEM (Gibco) 
supplemented with 10% foetal calf serum (Gibco), 1% penicillin and streptomycin, 1% L-
Glutamine, 1% of non-essential amino acids) at a final concentration of 100 mg ml-1 at 37oC 
and 5% CO2. After 24 h, the conditioned medium containing the microsphere ion extracts was 
collected, filtered using 0.22 μm syringe filters and used to prepare three serial dilutions with 
1:10 ratio using SC medium.  
2.2.4.2 MTT assay 
The evaluation of cytotoxicity was performed using a “Cell Growth Determination Kit, MTT 
based” (Sigma Adlrich, UK); for this purpose, 1x104 immortalised human bone marrow-
derived mesenchymal stem cells (hMSCs) were seeded in 96-well plate in 100 μl of SC 
medium. After 24 h, SC medium was replaced with ion extract conditioned medium or the 3 
serial dilutions prepared as shown in section 2.2.4.1. Moreover, SC medium alone or 
supplemented with 5% of DMSO were included as controls. After 24 h, cells were washed once 
with PBS and incubated during 3 h at 37oC and 5% of CO2 with a SC medium supplemented 
with 10% of MTT solution. After incubation, media was aspirated and 100 μl of DMSO was 
added to each well and incubated for 15 min in gentle shaking to facilitate the formazan salts 
dissolution. Absorbance was read using a plate reader at 570 nm, setting 650 nm as reference. 
The cell viability percent was calculated in comparison to SC medium control using the 
following formula: 
𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =
𝑂𝐷570s
𝑂𝐷570𝑐
                                 (2)  
Where, OD570s and OD570c are the optical densities measured in the samples of interest and 
in the control, respectively. 
2.2.4.3 Direct seeding of cells on porous CaP microspheres 
For direct seeding of cells onto the porous CaP microspheres, 2x104 immortalized GFP-labelled 
human bone marrow-derived mesenchymal stem cells (hMSCs) were seeded on 10 mg of 
sterile microspheres into low-adherent 48-well plates previously coated with 1% (w/v) solution 
of poly(2-hydroxyethyl methacrylate) (poly-HEMA) and Ethanol 95% in SC medium. Cells 
were cultured by 14 days at 37oC and 5% CO2. The media was refreshed every 48 h. 
2.2.4.4 Presto Blue assay 
Metabolic activity of cells seeded on porous CaP glass microspheres was analysed using Presto 
Blue reagent at day 2, day 5 and day 12 according to the manufacturer’s indications. Briefly, 
cells were incubated with a solution of SC medium supplemented with 10% of Presto Blue at 
37⁰C for 40 min. The fluorescence was then measured at 560 nm and 590 nm as excitation and 
emission wavelengths using a plate reader (Tecan infinite 200). 
2.2.4.5 Cell staining and imaging 
Cell imaging was performed at day 14 in paraformaldehyde-fixed cells. For Environmental 
Scanning Electron Microscopy (ESEM), post fixed cells were washed twice with distilled water 
and analysed using a FEI Quanta 650 ESEM microscope. 
For confocal laser scanning microscopy analysis, cell nuclei were counterstained with 10 μg 
ml-1 of Hoechst 33258 for 10 min and cytoskeletal actin fibres were visualised using 
Vectashield mounting medium containing TRITC-Phalloidin (Vector Laboratories, UK). 
Confocal laser scanning microscopy was carried out on a Zeiss LSM 880 microscope using a 
a 10x 0.3 NA or 20x 0.5 NA objectives setting 5.77 μm and 1.77 μm spacing respectively and 
sequential imaging channels for each fluorophore. The following lasers were assigned to each 
fluorophore:  Hoechst: λex. 405 nm laser, λem. 405-437 nm, FITC-GFP: λex. 488nm laser, λem. 
496-556 nm, TRITC-Phalloidin:  λex. 561nm laser, λem. 564-600 nm. 
2.2.5 Statistical analysis 
For the cell study, one biological replicate was included in each assay. Data is presented as 
mean ± SEM. Statistical analysis was performed using GraphPad PRISM 7.01 software 
package via the One-way ANOVA with Tukey’s multiple comparison post hoc test. A 95% 
confidence level was considered significant.  
 
3. Results 
Both solid (non-porous) and highly porous CaP glass microspheres were produced via the 
flame spheroidisation process as shown in Figure 1. Figure 1a shows uniform non-porous glass 
microspheres with an average diameter of 108 (±10) µm.  Figure 1b represents the yield and 
distribution of pore morphologies achieved utilising the novel manufacturing process 
developed herein. Figure 1c shows a SEM image of a porous CaP glass microsphere with a 
wide distribution of smaller surface pores (ranging from macroporous sized features to 30 μm). 
Whilst Figures 1d+e highlights porous CaP glass microspheres with a combination of larger 
(between 50 - 80 μm) and smaller (from 5 - 20 μm) surface pores. Comparatively larger surface 
pores with similar internal larger interconnected pores were also produced (as shown in Figure 
1e).  
 
Figure 1: Representative SEM images of solid (non-porous) and porous CaP glass 
microspheres: a) Shows the distribution and yield of solid microspheres, b) Scale-up 
production of porous glass microspheres, c) Surface morphology of porous glass microsphere 
with smaller surface pores, d) Porous glass microsphere with a mixture of small and large 
a b 
c d e 
f g 
surface pores,  e) Porous glass microsphere with comparatively larger surface pores, f) Cross-
sectional SEM images of resin embedded porous CaP glass microspheres with interconnected 
open porosity, and g) Microspheres with surface pores (indicated with blue arrows) and solid 
core (indicated by yellow arrows).  
The cross-sectional SEM images of the porous microspheres (as shown in Figure 1f) revealed 
the inner porosity and interconnectivity of the pores, which showed that the microspheres 
consisted mainly of smaller pores embedded within larger pores. Microspheres with surface 
porosity and a solid core were also manufactured as can be seen in Figure 1g when altering 
manufacturing parameters i.e. size of initial particles. 
Characterisation of the CaP microspheres revealed posority levels of up to and over 76 (±5)% 
could be achived depending on the process parameters. Mercury porosimetry analysis of porous 
and solid CaP glass microspheres is shown in Figure 2a. The mean pore size distibution for the 
porous microspheres was determined to be approxiamtely 55 (±8) μm and also revealed inner 
pore features at the submicron and nano porosity levels (as seen in Figure 2b). Figure 2c 
highlights the percentage porosity change with increasing glass powder/porogen ratio content. 
The porosity of the compact solid microspheres (with a size range of between 100-125 μm) 
was found to be approximaltely 37 (±4) % where the interparticulate gaps between the solid 
microspheres were characterised as pores. However, for the porous glass microspheres 
approximately 76 (±5) % porosity levels were obtained. The surface area (ascertained via BET 
analysis) for the non-porous CaP microspheres was 0.09 (±0.01) m2g-1 and the porous CaP 
microspheres were found to have an order of magnitude higher surface area which ranged from 
between 0.34 (±0.02) to 0.90 (±0.03) m2g-1  dependant on the micropshere size range selected 
(see Figure 2d). For example, the lower diameter size range porous microspheres (i.e between 
63-125 μm) revealed a significant number of larger surface pores (hence a lower surface area 
of 0.34 m2g-1). Whilst, a comparatively higher surface area (0.9 m2g-1) was obtained for the 
larger diameter size range porous microspheres (i.e. between 200-300 μm) which revealed a 
larger number of smaller surface pores. 
 
 Figure 2: Porosity and surface area properties of CaP glass microspheres: a) Mercury 
intrusion curves of the solid and porous CaP glass microspheres, b) log differential intrusion 
curves of solid and porous CaP glass microspheres highlighting the range of pore sizes 
achieved, c) Porosity (%) of microspheres obtained  with increasing glass powder/porogen 
ratio content and d) BET surface area analysis of the solid and porous CaP glass microspheres 
(between 63 to 300 µm diameter ranges). 
EDX analysis confirmed negligible changes in glass compositions before and after 
spheroidisation (see Figure 3a), with only slight localised increases in Ca content which were 
mainly observed around the pores created. 
Porous CaP microspheres revealed an approximate 30% mass loss compared to 9% mass loss 
for the solid non-porous microspheres over a 28 day degradation period in ultra-purified water 
at 37oC (see Figure 3b).  Figures 3c-f show increased ion release profiles (for example, Ca2+ 
~47 (±3) ppm, PO4
3- ~49 (±3) ppm, and Mg2+ ~20 (±3)  ppm per day) for the porous CaP glass 
microspheres (size range 125-200 μm) compared to the solid non-porous microspheres (Ca2+ 
~45 (±1)  ppm, PO4
3- ~34 (±2) ppm, and Mg2+ ~13 (±1)  ppm per day) when degraded in 
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standard cell culture medium (DMEM) at 37oC for 14 days, which was attributed to their higher 
surface area.  
 
Figure 3: Chemical composition, degradation and ion release profiles of CaP glass 
microspheres: a) Chemical composition of the glass (ascertained via EDX analysis) before and 
after spheroidisation, b) Mass loss profiles of solid and porous CaP glass microspheres during  
degradation in ultra purified over 28 days at 37oC, and c-e) Cumulative ion release profile 
(Ca2+, PO4
3-, and Mg2+) of solid and porous CaP microspheres in DMEM cell culture medium 
over 14 days at 37oC, and f) ion release rates (ppm per day) of solid and porous CaP 
microspheres calculated from the linear cumulative ion release profiles (observed in c-e). 
 
 
P2O5 CaO Na2O MgO
0
10
20
30
40
50 CaP glass powder
CaP porous MS
Inorganic elements
E
le
m
e
n
ta
l 
c
o
m
p
o
si
ti
o
n
(m
o
l%
)
 
0 10 20 30
0
10
20
30
40 CaP solid MS
CaP porous MS
Degradation time (day)
M
a
ss
 l
o
ss
 (
%
)
 
0 2 4 6 8 10 12 14
0
200
400
600
800 Cell culture medium (DMEM)
CaP solid MS
CaP porous MS
Dissolution time (Day)
C
u
m
u
la
ti
v
e
 C
a
2
+
 r
el
ea
se
 (
p
p
m
)
 
0 2 4 6 8 10 12 14
0
200
400
600
800 Cell culture medium (DMEM)
CaP solid MS
CaP porous MS
Dissolution time (Day)
C
u
m
u
la
ti
v
e
 P
O
4
3
-  
re
le
a
se
 (
p
p
m
)
 
0 2 4 6 8 10 12 14
0
200
400
600
800 Cell culture medium (DMEM)
CaP solid MS
CaP porous MS
Dissolution time (Day)
C
u
m
u
la
ti
v
e
 M
g
2
+
 r
el
ea
se
 (
p
p
m
)
 
Ca
2+
PO4
3-
Mg
2+
0
20
40
60
Cell culture medium (DMEM)
CaP solid MS
CaP porous MS
Ions
Io
n
 r
el
ea
se
 r
a
te
(p
p
m
. 
d
a
y
-1
)
a b 
c d 
e f 
The biocompatibility evaluation of the porous CaP glass microspheres was performed through 
MTT test according to the ISO standard 10993-5. Results revealed that the proliferation rate of 
hMSCs cultured with the material ion extracts or with 1:10 serial dilutions was higher than 70 
% of the SC medium control (1x: 81% ± 21; 1/10x: 72% ± 16; 1/100x: 103% ± 19; 1/1000x: 
87%± 26), as showed in Figure 4a. The suitability of the microspheres to support cell adhesion 
and growth was also evaluated by culturing cells directly onto the CaP glass microspheres for 
up to 14 days in SC medium. Their metabolic activity was analysed at 12 h, day 5 and day 12 
which showed a progressive increase of the signal over time, suggesting an increase in cell 
numbers (see Figure 4b). 
 
Figure 4: Biocompatibility evaluation of porous CaP glass microspheres according to ISO 
10993. a) Results of MTT test showing the relative viability of cells cultured with ion extract 
conditioned medium (1x) and for the following three serial dilutions (1/10x, 1/100x, 1/1000x). 
The SC medium only and SC supplemented with 5 % DMSO were included as control. b) Shows 
the results of cell metabolic activity for porous CaP microspheres cultured at 12h, day 5 and 
day 12 after seeding (*p < 0.05, **p < 0.01). 
Initial observations confirmed through ESEM imaging showed that the cells were indeed 
attached and had spread on the microspheres and could also be observed in their inner pore 
structures (indicated by yellow arrows) where they acquired a 3D conformation (Figure 5a, b). 
Further detailed analysis using scanning laser confocal microscopy was performed at day 14, 
where it was clearly observed that cells were attached to the microspheres and grew on and 
around them forming macro-aggregates (Figure 5c, d). Moreover, to ascertain how far the stem 
cells had migrated inside the porous microspheres, z-stack images were taken which confirmed 
that the cells were present up to half-way inside the porous microspheres (see Figure 5e).  
a b 
  
Figure 5: a) ESEM image of stem cell-microsphere aggregates; the yellow arrows indicate 
hMSCs attached and bridging across several microspheres, b) ESEM image shows 
colonisation of hMSCs within the pores of the microspheres (yellow arrows), c, d) 
Representative confocal images (in single plane and z-stacked mode) of GFP-labelled hMSCs 
seeded on porous CaP microspheres at day 14, and e) cross sectioned representation of a 
microsphere and its respective single plane sectioned images; white arrows indicate cells 
a b 
c d 
e 
which have migrated internally within the microsphere. hMSCs are seen in green (labelled 
using GFP), the nuclei are stained in blue (Hoechst 33259) and the cytoskeleton is seen in red 
(Phalloidin), respectively. Scale bars: 100 μm (c), 50 μm (d) and 25 μm (e).   
 
4. Discussion 
Orthobiologic therapies are being developed to help improve the long-term health of patients 
suffering from disabling musculoskeletal disorders and is a rapidly advancing field which 
utilises cell-based therapies and biomaterials to promote healing and offers exciting alternatives 
to traditional orthopaedic options.  
The results above demonstrate (for the first time) a highly successful production process to 
manufacture highly porous CaP glass microspheres. The manufacturing route developed relies 
on a number of key parameters including the chemical and physical interaction of the porogen 
with the glass the glass viscosity, along with both being delivered within a suitable thermal 
processing window.  
 
Figure 6 highlights a schematic representation of the morphological changes that occur and the 
proposed underlying mechanisms to produce the porous glass microspheres. The 
manufacturing process involved selection of a glass formulation that will not only melt but then 
allows it to reach a temperature where the viscosity was sufficiently low such that entrapment 
of the porogen gas could occur within the molten particle, which was itself driven to produce 
a spherical morphology due to surface tension from being ejected from the flame. The kinetics 
of decomposition must ideally be sufficiently slow for gas entrapment and adequately fast for 
pore formation to occur. 
 
 Figure 6: Schematic representation of the proposed mechanism for manufacturing porous 
glass microspheres via the flame spheroidisation process.  
 
Critical to this process was not only the choice of pore forming agent but also the size of the 
porogens and in some cases how they were applied to affect the pore sizes and levels produced. 
As shown in Figure 1, a range of pores, pore sizes and quantities are achievable from this 
process. Furthermore, it was also found that varying the initial particle size and porogen 
quantities, enabled control over the size of the surface and interconnected pores.  
Examining the CaP porous glass microspheres reported here the porosity (as measured via 
mercury intrusion) showed an increase from approximately 37% for loosely packed non-porous 
microspheres, which is typical for packed spheres, to over 76% for the porous microspheres 
(see Figures 2a-c). These results revealed that the inter-particulate gaps also contributed to the 
overall porosity levels measured for both the solid (non-porous) and the porous microspheres.  
This study also showed that both porogen quantity and microparticles size also effected pore 
size and surface area, as higher quantities of porogen resulted in increased porosity (see Figures 
2c) and smaller (63 -125µm) particle sizes resulted in larger pore sizes. BET analysis confirmed 
that surface area could also be controlled up to approximately 0.9 m2 g-1 (see Figures 2d). These 
values appeared to be low, however the resulting porous microspheres resemble a shell-like 
structure with fully interconnected pores, which was reflected in the values obtained. 
Addition of porogen during the spheroidisation process also resulted in slightly localised 
increase in Ca content which were mainly observed around the pores (see Figures 3a) and were 
attributed to the use of Ca-based porogens utilised. The introduction of porosity also resulted 
in an increase in mass loss during degradation (see Fig 3b) and increased the release of ions as 
expected due to the increased surface area achieved. As such, by simple selection of glass 
formulations and particle size, the microsphere porosity levels (which in turn relates to their 
surface area) could easily be manipulated to control ion release rates (as seen in Figures 3c-e) 
of potentially biotherapeutic ions for specific end applications.  
The advantages of larger surface pores are that they could be exploited for applications which 
require faster ingress of fluids or media through the internal microsphere structure and smaller 
pores within could be utilised for the entrapment of particulate materials, for example in 
separation sciences. In particular for biomedical applications, larger pores would be beneficial 
to accommodate particular cell types, in order to promote tissue engineering or regeneration 
activities, whereas smaller surface pores could be beneficial for controlling release of drugs 
and/or other small biological components or biomolecules, entrapped within. Furthermore, 
where biological cell and material interactions are concerned, the inter-particulate gaps 
between the microspheres along with the enhanced levels of interconnected porosity created 
using this simple, single stage manufacturing process, could enable permeation of nutrients and 
waste products throughout the entire cell/material constructs [42-44].  
Recently it has been shown that cell fate, in particular stem cell phenotype, could be influenced  
by controlled release of specific ions from inorganic materials [45]. Through simple 
compositional tailoring, the formulation of CaP glasses can easily be modified to release ions 
of specific interest. The solid and porous microspheres manufactured in this study revealed 
release of Ca2+, PO4
3- and Mg2+ ions ranging from 45-47, 34-49 and 13-20 ppm per day (see 
Figure 3f). Furthermore, studies by Ahmed et al [46], showed that phosphate anionic species 
(ranging from ortho, pyro, meta and polyphosphates) could also be controlled, by simple 
tailoring of the starting glass formulations.  
Figure 7 highlights some of the ions which could be released from CaP glasses and their 
potential biotherapeutic roles in bone repair and regeneration. Ca2+ ions are known to stimulate 
proliferation and differentiation of osteoblasts as well as extracellular matrix mineralisation 
[47]  whilst Mg2+ ions can promote new bone formation [48]. Moreover, PO4
3- ions are required 
for calcium phosphate crystal deposition [49] and extracellular matrix mineralisation while Na+ 
ions are mainly found in extracellular fluid [50].  
 Figure 7: Biotherapeutic ions which can be released from CaP glass and their role in bone 
tissue formation. 
Other biotherapeutic ions can also be released from the CaP microspheres such as Sr2+ [12], 
Cu2+ [9] and Ag+ [10] by simply doping the glass composition with the desired metal oxide. For 
instance, Sr2+ ions are known to inhibit osteoclast activity whilst promoting osteogenesis of 
mesenchymal stem cells in vitro and in vivo [51], Ag2+ and Cu2+ ions have both demonstrated 
antimicrobial properties while Cu2+ ions have been also shown to promote the proliferation of 
endothelial growth factors and fibroblast growth factor 2 (FGF-2), which are associated with 
the angiogenesis process [9]. 
This study also demonstrated that the porous microspheres produced were biocompatible (see 
Figure 4a) according to the standard ISO 10993-5 (i.e. used for the biological evaluation of 
biomedical devices). Moreover, when the cells were seeded and cultured directly onto the 
microspheres, they were not only able to attach but had also migrated to within the centre of 
the microspheres, revealing colonisation of the inner pore structures (see Figure 5e). The pores 
formed presented the cells with a high surface area and a niche environment for the cells to 
grow and proliferate, acting as sites for cell culture [52]. This niche pore environment could 
also reduce any potential shear stresses experienced by the cells and provide protection for cells 
from getting damaged via inter-particle abrasion. Furthermore, the pores also closely resemble 
the native 3D conformation of bone tissue [53]. It has also been proposed that a porous 
environment would favour the capture and utilisation of cell secreted factors close to where the 
cells reside  in order to further influence cell phenotype [45].  
The porous microspheres developed in this study constitute a versatile and highly promising 
technology for wider applications in tissue engineering and regenerative medicine (with a 
particular focus in bone regeneration) as initial examples. Indeed, doping the starting glass 
formulations with specific biotherapeutic ions could also address other key aspects of bone 
regeneration to include angiogenesis, osteogenesis and control of osteoclast activity, all 
potentially also coupled with antimicrobial properties.  Further studies are on-going aimed at 
investigating more in-depth the bone tissue regenerative potential of these microspheres as well 
as exploring their potential use in alternate biomedical applications.  
The porous glass microsphere production process developed herein offers a new cost-effective 
single stage manufacturing process, with demonstrated scale-up potential and with production 
levels in the range of kg’s per hour at lab scale, which could easily be further scaled-out to 
commercial scales. Follow-on investigations are on-going to explore utility of this 
manufacturing process for other glass types (i.e. borates and silicates including glass-ceramics).   
 
5. Conclusions 
This study highlights a novel flame spheroidisation process to manufacture highly porous CaP 
glass microspheres. Microspheres with a range of surface and fully interconnected porosity 
from 52 (±5) to 76 (±5) % were manufactured by simply manipulating process parameters such 
as the ratios of glass particles to porogen used (from 1:1 to 1:3) including the oxy-acetylene 
gas ratios.  
The increase in porosity levels of the microspheres was shown to accelerate degradation over 
a 28 day degradation period (i.e. a 30% mass loss was observed for porous microspheres, 
compared to a 9% mass loss for the solid non-porous microspheres). The ion release profiles 
of the porous microspheres also revealed increasing rates as expected, compared to the non-
porous microspheres, which was attributed to their increased surface area profiles.  
The cell culture study revealed that the ion extracts from the CaP microspheres (utilising 
indirect cell culture method according to ISO 10993) did not exert any negative effect on the 
stem cells (hBM-MSCs). In addition, the direct cell culture study revealed that the porous 
microspheres supported cell attachment as well as proliferation and showed that the hBM-
MSCs had migrated into and towards the centre of the microspheres. The pore sizes and 
porosity levels achieved opens up the potential for use of these porous CaP microspheres for 
other biomedical applications in addition to the proposed orthobiologic applications. 
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